...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >In Vitro Activity of Caspofungin Combined with Sulfamethoxazole against Clinical Isolates of Aspergillus spp.
【24h】

In Vitro Activity of Caspofungin Combined with Sulfamethoxazole against Clinical Isolates of Aspergillus spp.

机译:卡泊芬净与磺胺甲恶唑联合使用对曲霉菌临床分离株的体外活性。

获取原文
获取原文并翻译 | 示例

摘要

Caspofungin (CAS) inhibits fungal cell wall synthesis. Sulfamethoxazole (SMX) inhibits folate biosynthesis and is active in vitro against Aspergillus spp. We studied the activities of the combination of CAS and SMX against 31 Aspergillus isolates and compared them with that of SMX combined with amphotericin B (AMB) or itraconazole (ITC). MICs and minimal effective concentrations (MECs) were determined by the NCCLS broth microdilution method. With MIC endpoints, the combination of SMX and CAS showed synergy or synergy to additivity against 29 of 31 isolates. With MEC endpoints, synergy to additivity was found against 12 of 31 isolates and indifference was displayed against the rest of them. SMX in combination with AMB or ITC was not truly synergistic, while synergy to additivity was found for SMX-AMB and SMX-ITC against 17 of 31 and 3 of 12 isolates, respectively. No antagonism was found with any of the drug combinations. Further analysis of the synergy of CAS and SMX was performed by detailed measurement of hyphal length by microscopy and time-dependent 2,3-bis(2-methoxy-4-nitro-5-[(sulfenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT)-based hyphal damage experiments. With MEC endpoints, the combination of CAS and SMX was characterized by a greater than 50% decrease in hyphal length compared to the hyphal lengths achieved with double the concentration of each drug alone. The XTT-based hyphal damage studies showed a statistically significant (P < 0.05) reduction in viability with CAS and SMX in combination compared to the viabilities achieved with double the concentration of each drug alone. These findings support the synergy results found by using MIC endpoints and suggest that visual MEC measurements may not be sufficient to identify the synergistic interactions seen by more sensitive, quantitative methods. Animal models are required to validate the significance of the synergy of CAS and SMX against Aspergillus spp. observed in vitro.
机译:卡泊芬净(CAS)抑制真菌细胞壁合成。磺胺甲基异恶唑(SMX)抑制叶酸的生物合成,并在体外对曲霉属有活性。我们研究了CAS和SMX组合对31株曲霉菌的活性,并将其与SMX和两性霉素B(AMB)或伊曲康唑(ITC)组合的活性进行了比较。 MIC和最低有效浓度(MEC)通过NCCLS肉汤微稀释法测定。对于MIC终点,SMX和CAS的组合对31种分离株中的29种显示出协同作用或协同作用。对于MEC终点,发现对31个分离株中的12个具有加和作用的协同作用,对其余分离株表现出冷漠。 SMX与AMB或ITC的结合并不是真正的协同作用,而SMX-AMB和SMX-ITC的加性协同作用却分别针对31个分离株中的17个和12个分离株中的3个。在任何药物组合中均未发现拮抗作用。通过显微镜和时间相关的2,3-双(2-甲氧基-4-硝基-5-[[亚硫基氨基)羰基] -2H-氢氧化四唑对菌丝长度的详细测量,进一步分析了CAS和SMX的协同作用。基于(XTT)的菌丝破坏实验:与MEC终点相比,CAS和SMX的组合的特征在于,与单独使用每种药物的浓度加倍时所获得的菌丝长度相比,菌丝长度减少了50%以上。菌丝破坏研究表明,与单独使用每种药物的浓度加倍相比,CAS和SMX联合使用的生存力在统计学上有显着降低(P <0.05),这些发现支持使用MIC终点发现的协同作用结果,并表明MEC测量可能不足以识别通过更敏感的定量方法观察到的协同相互作用,需要动物模型来验证CAS和SMX协同对曲霉属体外观察。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号